Register entry

Vivus LLC

Registered sites
0
Drug products
10
Live patents
24
Countries
0
Base
Unknown
Sites

Facilities

0

No registered facilities

This company holds drug listings or approvals but operates no registered establishment of its own, which is normal for an NDA holder that outsources manufacturing.

Exclusivity

Patents

24

Unexpired Orange Book patents where this company is the application holder.

ProductActive ingredientExpiry
QSYMIAPHENTERMINE HYDROCHLORIDE; TOPIRAMATEJun 2028
QSYMIAPHENTERMINE HYDROCHLORIDE; TOPIRAMATEMay 2029
QSYMIAPHENTERMINE HYDROCHLORIDE; TOPIRAMATEJun 2029
Catalogue

Marketed products

10

Showing 10 of 10.

BrandGeneric nameFormCategory
PANCREAZEPANCRELIPASE LIPASE, PANCRELIPASE AMYLASE, and PANCRELIPASE PROTEASECAPSULE, DELAYED RELEASEBLA
PANCREAZEPANCRELIPASE LIPASE, PANCRELIPASE AMYLASE, and PANCRELIPASE PROTEASECAPSULE, DELAYED RELEASEBLA
PANCREAZEPANCRELIPASE LIPASE, PANCRELIPASE AMYLASE, and PANCRELIPASE PROTEASECAPSULE, DELAYED RELEASEBLA
PANCREAZEPANCRELIPASE LIPASE, PANCRELIPASE AMYLASE, and PANCRELIPASE PROTEASECAPSULE, DELAYED RELEASEBLA
PANCREAZEPANCRELIPASE LIPASE, PANCRELIPASE AMYLASE, and PANCRELIPASE PROTEASECAPSULE, DELAYED RELEASEBLA
PANCREAZEPANCRELIPASE LIPASE, PANCRELIPASE AMYLASE, and PANCRELIPASE PROTEASECAPSULE, DELAYED RELEASEBLA
Qsymiaphentermine and topiramateCAPSULE, EXTENDED RELEASENDA
Qsymiaphentermine and topiramateCAPSULE, EXTENDED RELEASENDA
Qsymiaphentermine and topiramateCAPSULE, EXTENDED RELEASENDA
Qsymiaphentermine and topiramateCAPSULE, EXTENDED RELEASENDA
Provenance

Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.